<DOC>
	<DOCNO>NCT00561236</DOCNO>
	<brief_summary>The use intravitreal corticosteroid management ocular inflammatory disease recently gain widespread acceptance . The purpose study determine use intravitreal triamcinolone associate suppression endogenous cortisol production , generally admit patient treated oral parenteral corticosteroid therapy .</brief_summary>
	<brief_title>Does Intravitreal Injection Triamcinolone Acetonide Impairs Adrenal Function</brief_title>
	<detailed_description>The normalcy hypothalamic- pituitary- adrenal axis ( HPA axis ) enrol subject assess intravitreal injection 4mg triamcinolone one day , one week two week . Patients abnormal HPA axis re-tested four week later HPA axis function return normal . The HPA axis assess low dose ( 1mcg ) intravenous corticotropin ( ACTH ) stimulation test , cortisol level sample , 30 minute 60 minute 1mcg ACTH IV injection .</detailed_description>
	<mesh_term>Adrenal Insufficiency</mesh_term>
	<mesh_term>Triamcinolone hexacetonide</mesh_term>
	<mesh_term>Triamcinolone Acetonide</mesh_term>
	<mesh_term>Triamcinolone</mesh_term>
	<mesh_term>Triamcinolone diacetate</mesh_term>
	<criteria>patient receive intravitreous injection triamcinolone 4mg patient receive steroid form , except intravitreous administration</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>September 2016</verification_date>
</DOC>